- VION Biosciences is building a differentiated life-sciences platform supporting mRNA and broader RNA and oligonucleotide therapeutic development across delivery materials, formulation, analytical tools, and functional immune monitoring.
- Through Echelon Biosciences, VION supports RNA-delivery research and development with specialized and ionizable lipids, LNP formulation products, mRNA synthesis and formulation services, and expression-screening capabilities.
- Through Cellular Technology Limited, VION provides ELISpot and FluoroSpot instruments, consumables, software, and CRO services to characterize T- and B-cell responses across autoimmune and other immune-mediated diseases, vaccines, immuno-oncology, cell therapy, and other immune-modulating therapeutic programs.
- VION continues to expand its RNA-enabling capabilities through internal innovation, commercial partnerships, and selective strategic investment across delivery, analytics, manufacturing inputs, and immune-response monitoring.